Stay updated on Pembrolizumab for Cancer of Unknown Primary Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Cancer of Unknown Primary Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Cancer of Unknown Primary Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A new page revision tag v3.5.5 was added, replacing the previous v3.5.4 tag. This indicates a minor update to the page record rather than a change to study content or functionality.
    Difference
    0.1%
    Check dated 2026-06-05T20:46:35.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    A new site revision v3.5.4 was added, replacing the previous revision v3.5.3. This reflects a routine platform update without changes to study information.
    Difference
    0.1%
    Check dated 2026-05-15T15:28:46.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Adds a Results and Publications section with post-study outcomes and citations for the CUPem trial, including major publications; also removes earlier narrative summaries of efficacy and RECIST-based outcomes.
    Difference
    6%
    Check dated 2026-05-08T12:11:21.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page’s footer “Revision” label has been updated from v3.5.2 to v3.5.3, indicating a minor site/content system revision rather than a change to the clinical trial details.
    Difference
    0.1%
    Check dated 2026-04-24T05:51:47.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:09:27.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added and Revision: v3.4.3 removed from the page. This update does not change study details, eligibility criteria, or other user-facing content.
    Difference
    0.1%
    Check dated 2026-03-18T21:54:15.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Cancer of Unknown Primary Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Cancer of Unknown Primary Clinical Trial page.